ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Osteoarthritis Pain Drugs Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-1556
Home | Market Reports | Health | Health Conditions | Pain Management
Global Osteoarthritis Pain Drugs Market Insights and Forecast to 2028

Global Osteoarthritis Pain Drugs Market Insights and Forecast to 2028

Code: QYRE-Auto-1556
Report
January 2022
Pages:129
QYResearch
Description
Table of Content
Tables & Figures
FEATURED COMPANIES
Johnson & Johnson
Pfizer Inc
GlaxoSmithKline PLC
Mylan NV
Lilly
Sanofi
Abbott Laboratories
Bayer
Almatica Pharma
TEVA
Iroko Pharmaceuticals
Johnson Johnson
GlaxoSmithKline
Chugai Pharmaceutical
Mikasa Seiyaku
Russia
Sanofi S A
Sino Biopharmaceutical
Haohai Biological
SK Chemicals
Taisho Pharmaceutical
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
SEIKAGAKU CORPORATION
GSK
Crystal Genomics
Eli Lilly
Novartis
Horizon Pharma
Abbott
Daiichi Sankyo
Astellas Pharma
Tide Pharmaceutical
Hengrui Pharmaceutical
The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers.
Market Analysis and Insights: Global Osteoarthritis Pain Drugs Market

Due to the COVID-19 pandemic, the global Osteoarthritis Pain Drugs market size is estimated to be worth US$ 10420 million in 2022 and is forecast to a readjusted size of US$ 14530 million by 2028 with a CAGR of 5.7% during the review period.

Fully considering the economic change by this health crisis, Oral accounting for % of the Osteoarthritis Pain Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Medical Care segment is altered to an % CAGR throughout this forecast period.
The major players in global Methylcyclohexane market include Pfizer, Johnson & Johnson, GlaxoSmithKline, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Oral is the main type, with a share over 50%. Personal Care is the main application, which holds a share about 90%.
Global Osteoarthritis Pain Drugs Scope and Segment
Osteoarthritis Pain Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Pain Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Oral
Injection
External

Segment by Application

Medical Care
Personal Care

BY COMPANY

Pfizer
Bayer
SK Chemicals
GSK
Sanofi
Crystal Genomics
Johnson & Johnson
Sino Biopharmaceutical
Haohai Biological
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
Chugai Pharmaceutical
Mikasa Seiyaku
Taisho Pharmaceutical
Seikagaku Corporation
GlaxoSmithKline
Eli Lilly
Novartis
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
FEATURED COMPANIES
Johnson & Johnson
Pfizer Inc
GlaxoSmithKline PLC
Mylan NV
Lilly
Sanofi
Abbott Laboratories
Bayer
Almatica Pharma
TEVA
Iroko Pharmaceuticals
Johnson Johnson
GlaxoSmithKline
Chugai Pharmaceutical
Mikasa Seiyaku
Russia
Sanofi S A
Sino Biopharmaceutical
Haohai Biological
SK Chemicals
Taisho Pharmaceutical
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
SEIKAGAKU CORPORATION
GSK
Crystal Genomics
Eli Lilly
Novartis
Horizon Pharma
Abbott
Daiichi Sankyo
Astellas Pharma
Tide Pharmaceutical
Hengrui Pharmaceutical
1 Study Coverage
1.1 Osteoarthritis Pain Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Osteoarthritis Pain Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Osteoarthritis Pain Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Osteoarthritis Pain Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Osteoarthritis Pain Drugs Sales by Region
2.4.1 Global Osteoarthritis Pain Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Osteoarthritis Pain Drugs by Region (2023-2028)
2.5 Global Osteoarthritis Pain Drugs Revenue by Region
2.5.1 Global Osteoarthritis Pain Drugs Revenue by Region (2017-2022)
2.5.2 Global Osteoarthritis Pain Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Osteoarthritis Pain Drugs Sales by Manufacturers
3.1.1 Global Top Osteoarthritis Pain Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Osteoarthritis Pain Drugs in 2021
3.2 Global Osteoarthritis Pain Drugs Revenue by Manufacturers
3.2.1 Global Osteoarthritis Pain Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Pain Drugs Revenue in 2021
3.3 Global Osteoarthritis Pain Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Osteoarthritis Pain Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Osteoarthritis Pain Drugs Sales by Type
4.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2028)
4.2 Global Osteoarthritis Pain Drugs Revenue by Type
4.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Osteoarthritis Pain Drugs Price by Type
4.3.1 Global Osteoarthritis Pain Drugs Price by Type (2017-2022)
4.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Osteoarthritis Pain Drugs Sales by Application
5.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2028)
5.2 Global Osteoarthritis Pain Drugs Revenue by Application
5.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Osteoarthritis Pain Drugs Price by Application
5.3.1 Global Osteoarthritis Pain Drugs Price by Application (2017-2022)
5.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Osteoarthritis Pain Drugs Market Size by Type
6.1.1 North America Osteoarthritis Pain Drugs Sales by Type (2017-2028)
6.1.2 North America Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
6.2 North America Osteoarthritis Pain Drugs Market Size by Application
6.2.1 North America Osteoarthritis Pain Drugs Sales by Application (2017-2028)
6.2.2 North America Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
6.3 North America Osteoarthritis Pain Drugs Market Size by Country
6.3.1 North America Osteoarthritis Pain Drugs Sales by Country (2017-2028)
6.3.2 North America Osteoarthritis Pain Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Osteoarthritis Pain Drugs Market Size by Type
7.1.1 Europe Osteoarthritis Pain Drugs Sales by Type (2017-2028)
7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
7.2 Europe Osteoarthritis Pain Drugs Market Size by Application
7.2.1 Europe Osteoarthritis Pain Drugs Sales by Application (2017-2028)
7.2.2 Europe Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
7.3 Europe Osteoarthritis Pain Drugs Market Size by Country
7.3.1 Europe Osteoarthritis Pain Drugs Sales by Country (2017-2028)
7.3.2 Europe Osteoarthritis Pain Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Osteoarthritis Pain Drugs Market Size by Type
8.1.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Osteoarthritis Pain Drugs Market Size by Application
8.2.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Osteoarthritis Pain Drugs Market Size by Region
8.3.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Osteoarthritis Pain Drugs Market Size by Type
9.1.1 Latin America Osteoarthritis Pain Drugs Sales by Type (2017-2028)
9.1.2 Latin America Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
9.2 Latin America Osteoarthritis Pain Drugs Market Size by Application
9.2.1 Latin America Osteoarthritis Pain Drugs Sales by Application (2017-2028)
9.2.2 Latin America Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
9.3 Latin America Osteoarthritis Pain Drugs Market Size by Country
9.3.1 Latin America Osteoarthritis Pain Drugs Sales by Country (2017-2028)
9.3.2 Latin America Osteoarthritis Pain Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Type
10.1.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Application
10.2.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Country
10.3.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 SK Chemicals
11.3.1 SK Chemicals Corporation Information
11.3.2 SK Chemicals Overview
11.3.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 SK Chemicals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SK Chemicals Recent Developments
11.4 GSK
11.4.1 GSK Corporation Information
11.4.2 GSK Overview
11.4.3 GSK Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GSK Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GSK Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Crystal Genomics
11.6.1 Crystal Genomics Corporation Information
11.6.2 Crystal Genomics Overview
11.6.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Crystal Genomics Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Crystal Genomics Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson & Johnson Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
11.8 Sino Biopharmaceutical
11.8.1 Sino Biopharmaceutical Corporation Information
11.8.2 Sino Biopharmaceutical Overview
11.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sino Biopharmaceutical Recent Developments
11.9 Haohai Biological
11.9.1 Haohai Biological Corporation Information
11.9.2 Haohai Biological Overview
11.9.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Haohai Biological Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Haohai Biological Recent Developments
11.10 Zhejiang Chengyi Pharmaceutical
11.10.1 Zhejiang Chengyi Pharmaceutical Corporation Information
11.10.2 Zhejiang Chengyi Pharmaceutical Overview
11.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zhejiang Chengyi Pharmaceutical Recent Developments
11.11 Freda
11.11.1 Freda Corporation Information
11.11.2 Freda Overview
11.11.3 Freda Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Freda Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Freda Recent Developments
11.12 Bright Future
11.12.1 Bright Future Corporation Information
11.12.2 Bright Future Overview
11.12.3 Bright Future Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Bright Future Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bright Future Recent Developments
11.13 Jingfeng Pharmaceutical
11.13.1 Jingfeng Pharmaceutical Corporation Information
11.13.2 Jingfeng Pharmaceutical Overview
11.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Jingfeng Pharmaceutical Recent Developments
11.14 Chugai Pharmaceutical
11.14.1 Chugai Pharmaceutical Corporation Information
11.14.2 Chugai Pharmaceutical Overview
11.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Chugai Pharmaceutical Recent Developments
11.15 Mikasa Seiyaku
11.15.1 Mikasa Seiyaku Corporation Information
11.15.2 Mikasa Seiyaku Overview
11.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Mikasa Seiyaku Recent Developments
11.16 Taisho Pharmaceutical
11.16.1 Taisho Pharmaceutical Corporation Information
11.16.2 Taisho Pharmaceutical Overview
11.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Taisho Pharmaceutical Recent Developments
11.17 Seikagaku Corporation
11.17.1 Seikagaku Corporation Corporation Information
11.17.2 Seikagaku Corporation Overview
11.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Seikagaku Corporation Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Seikagaku Corporation Recent Developments
11.18 GlaxoSmithKline
11.18.1 GlaxoSmithKline Corporation Information
11.18.2 GlaxoSmithKline Overview
11.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 GlaxoSmithKline Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 GlaxoSmithKline Recent Developments
11.19 Eli Lilly
11.19.1 Eli Lilly Corporation Information
11.19.2 Eli Lilly Overview
11.19.3 Eli Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Eli Lilly Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Eli Lilly Recent Developments
11.20 Novartis
11.20.1 Novartis Corporation Information
11.20.2 Novartis Overview
11.20.3 Novartis Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Novartis Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Novartis Recent Developments
11.21 Horizon Pharma
11.21.1 Horizon Pharma Corporation Information
11.21.2 Horizon Pharma Overview
11.21.3 Horizon Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Horizon Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Horizon Pharma Recent Developments
11.22 Abbott
11.22.1 Abbott Corporation Information
11.22.2 Abbott Overview
11.22.3 Abbott Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Abbott Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Abbott Recent Developments
11.23 Mylan
11.23.1 Mylan Corporation Information
11.23.2 Mylan Overview
11.23.3 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Mylan Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Mylan Recent Developments
11.24 Daiichi Sankyo
11.24.1 Daiichi Sankyo Corporation Information
11.24.2 Daiichi Sankyo Overview
11.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Daiichi Sankyo Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Daiichi Sankyo Recent Developments
11.25 TEVA
11.25.1 TEVA Corporation Information
11.25.2 TEVA Overview
11.25.3 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 TEVA Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 TEVA Recent Developments
11.26 Almatica Pharma
11.26.1 Almatica Pharma Corporation Information
11.26.2 Almatica Pharma Overview
11.26.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 Almatica Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Almatica Pharma Recent Developments
11.27 Astellas Pharma
11.27.1 Astellas Pharma Corporation Information
11.27.2 Astellas Pharma Overview
11.27.3 Astellas Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.27.4 Astellas Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Astellas Pharma Recent Developments
11.28 Tide Pharmaceutical
11.28.1 Tide Pharmaceutical Corporation Information
11.28.2 Tide Pharmaceutical Overview
11.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.28.4 Tide Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Tide Pharmaceutical Recent Developments
11.29 Iroko Pharmaceuticals
11.29.1 Iroko Pharmaceuticals Corporation Information
11.29.2 Iroko Pharmaceuticals Overview
11.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.29.4 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 Iroko Pharmaceuticals Recent Developments
11.30 Hengrui Pharmaceutical
11.30.1 Hengrui Pharmaceutical Corporation Information
11.30.2 Hengrui Pharmaceutical Overview
11.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.30.4 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.30.5 Hengrui Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Osteoarthritis Pain Drugs Industry Chain Analysis
12.2 Osteoarthritis Pain Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Osteoarthritis Pain Drugs Production Mode & Process
12.4 Osteoarthritis Pain Drugs Sales and Marketing
12.4.1 Osteoarthritis Pain Drugs Sales Channels
12.4.2 Osteoarthritis Pain Drugs Distributors
12.5 Osteoarthritis Pain Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Osteoarthritis Pain Drugs Industry Trends
13.2 Osteoarthritis Pain Drugs Market Drivers
13.3 Osteoarthritis Pain Drugs Market Challenges
13.4 Osteoarthritis Pain Drugs Market Restraints
14 Key Findings in The Global Osteoarthritis Pain Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Pfizer Inc
GlaxoSmithKline PLC
Mylan NV
Lilly
Sanofi
Abbott Laboratories
Bayer
Almatica Pharma
TEVA
Iroko Pharmaceuticals
Johnson Johnson
GlaxoSmithKline
Chugai Pharmaceutical
Mikasa Seiyaku
Russia
Sanofi S A
Sino Biopharmaceutical
Haohai Biological
SK Chemicals
Taisho Pharmaceutical
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
SEIKAGAKU CORPORATION
GSK
Crystal Genomics
Eli Lilly
Novartis
Horizon Pharma
Abbott
Daiichi Sankyo
Astellas Pharma
Tide Pharmaceutical
Hengrui Pharmaceutical
List of Tables
    Table 1. Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injection
    Table 4. Major Manufacturers of External
    Table 5. Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Osteoarthritis Pain Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Osteoarthritis Pain Drugs Sales by Region (2017-2022) & (M Dose)
    Table 8. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2017-2022)
    Table 9. Global Osteoarthritis Pain Drugs Sales by Region (2023-2028) & (M Dose)
    Table 10. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2023-2028)
    Table 11. Global Osteoarthritis Pain Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2017-2022)
    Table 13. Global Osteoarthritis Pain Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2023-2028)
    Table 15. Global Osteoarthritis Pain Drugs Sales by Manufacturers (2017-2022) & (M Dose)
    Table 16. Global Osteoarthritis Pain Drugs Sales Share by Manufacturers (2017-2022)
    Table 17. Global Osteoarthritis Pain Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2017-2022)
    Table 19. Osteoarthritis Pain Drugs Price by Manufacturers (2017-2022) &(US$/Dose)
    Table 20. Global Osteoarthritis Pain Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Osteoarthritis Pain Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Pain Drugs as of 2021)
    Table 22. Osteoarthritis Pain Drugs Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Osteoarthritis Pain Drugs Product Offered
    Table 24. Date of Manufacturers Enter into Osteoarthritis Pain Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
    Table 27. Global Osteoarthritis Pain Drugs Sales by Type (2023-2028) & (M Dose)
    Table 28. Global Osteoarthritis Pain Drugs Sales Share by Type (2017-2022)
    Table 29. Global Osteoarthritis Pain Drugs Sales Share by Type (2023-2028)
    Table 30. Global Osteoarthritis Pain Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Osteoarthritis Pain Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Osteoarthritis Pain Drugs Revenue Share by Type (2017-2022)
    Table 33. Global Osteoarthritis Pain Drugs Revenue Share by Type (2023-2028)
    Table 34. Osteoarthritis Pain Drugs Price by Type (2017-2022) & (US$/Dose)
    Table 35. Global Osteoarthritis Pain Drugs Price Forecast by Type (2023-2028) & (US$/Dose)
    Table 36. Global Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
    Table 37. Global Osteoarthritis Pain Drugs Sales by Application (2023-2028) & (M Dose)
    Table 38. Global Osteoarthritis Pain Drugs Sales Share by Application (2017-2022)
    Table 39. Global Osteoarthritis Pain Drugs Sales Share by Application (2023-2028)
    Table 40. Global Osteoarthritis Pain Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Osteoarthritis Pain Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Osteoarthritis Pain Drugs Revenue Share by Application (2017-2022)
    Table 43. Global Osteoarthritis Pain Drugs Revenue Share by Application (2023-2028)
    Table 44. Osteoarthritis Pain Drugs Price by Application (2017-2022) & (US$/Dose)
    Table 45. Global Osteoarthritis Pain Drugs Price Forecast by Application (2023-2028) & (US$/Dose)
    Table 46. North America Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
    Table 47. North America Osteoarthritis Pain Drugs Sales by Type (2023-2028) & (M Dose)
    Table 48. North America Osteoarthritis Pain Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Osteoarthritis Pain Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
    Table 51. North America Osteoarthritis Pain Drugs Sales by Application (2023-2028) & (M Dose)
    Table 52. North America Osteoarthritis Pain Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Osteoarthritis Pain Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Osteoarthritis Pain Drugs Sales by Country (2017-2022) & (M Dose)
    Table 55. North America Osteoarthritis Pain Drugs Sales by Country (2023-2028) & (M Dose)
    Table 56. North America Osteoarthritis Pain Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Osteoarthritis Pain Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
    Table 59. Europe Osteoarthritis Pain Drugs Sales by Type (2023-2028) & (M Dose)
    Table 60. Europe Osteoarthritis Pain Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Osteoarthritis Pain Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
    Table 63. Europe Osteoarthritis Pain Drugs Sales by Application (2023-2028) & (M Dose)
    Table 64. Europe Osteoarthritis Pain Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Osteoarthritis Pain Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Osteoarthritis Pain Drugs Sales by Country (2017-2022) & (M Dose)
    Table 67. Europe Osteoarthritis Pain Drugs Sales by Country (2023-2028) & (M Dose)
    Table 68. Europe Osteoarthritis Pain Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Osteoarthritis Pain Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
    Table 71. Asia Pacific Osteoarthritis Pain Drugs Sales by Type (2023-2028) & (M Dose)
    Table 72. Asia Pacific Osteoarthritis Pain Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Osteoarthritis Pain Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
    Table 75. Asia Pacific Osteoarthritis Pain Drugs Sales by Application (2023-2028) & (M Dose)
    Table 76. Asia Pacific Osteoarthritis Pain Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Osteoarthritis Pain Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Osteoarthritis Pain Drugs Sales by Region (2017-2022) & (M Dose)
    Table 79. Asia Pacific Osteoarthritis Pain Drugs Sales by Region (2023-2028) & (M Dose)
    Table 80. Asia Pacific Osteoarthritis Pain Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Osteoarthritis Pain Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
    Table 83. Latin America Osteoarthritis Pain Drugs Sales by Type (2023-2028) & (M Dose)
    Table 84. Latin America Osteoarthritis Pain Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Osteoarthritis Pain Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
    Table 87. Latin America Osteoarthritis Pain Drugs Sales by Application (2023-2028) & (M Dose)
    Table 88. Latin America Osteoarthritis Pain Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Osteoarthritis Pain Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Osteoarthritis Pain Drugs Sales by Country (2017-2022) & (M Dose)
    Table 91. Latin America Osteoarthritis Pain Drugs Sales by Country (2023-2028) & (M Dose)
    Table 92. Latin America Osteoarthritis Pain Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Osteoarthritis Pain Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Osteoarthritis Pain Drugs Sales by Type (2017-2022) & (M Dose)
    Table 95. Middle East and Africa Osteoarthritis Pain Drugs Sales by Type (2023-2028) & (M Dose)
    Table 96. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Osteoarthritis Pain Drugs Sales by Application (2017-2022) & (M Dose)
    Table 99. Middle East and Africa Osteoarthritis Pain Drugs Sales by Application (2023-2028) & (M Dose)
    Table 100. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2017-2022) & (M Dose)
    Table 103. Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2023-2028) & (M Dose)
    Table 104. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Pfizer Corporation Information
    Table 107. Pfizer Description and Major Businesses
    Table 108. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 109. Pfizer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Pfizer Recent Developments
    Table 111. Bayer Corporation Information
    Table 112. Bayer Description and Major Businesses
    Table 113. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 114. Bayer Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Bayer Recent Developments
    Table 116. SK Chemicals Corporation Information
    Table 117. SK Chemicals Description and Major Businesses
    Table 118. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 119. SK Chemicals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. SK Chemicals Recent Developments
    Table 121. GSK Corporation Information
    Table 122. GSK Description and Major Businesses
    Table 123. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 124. GSK Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. GSK Recent Developments
    Table 126. Sanofi Corporation Information
    Table 127. Sanofi Description and Major Businesses
    Table 128. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 129. Sanofi Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Sanofi Recent Developments
    Table 131. Crystal Genomics Corporation Information
    Table 132. Crystal Genomics Description and Major Businesses
    Table 133. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 134. Crystal Genomics Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Crystal Genomics Recent Developments
    Table 136. Johnson & Johnson Corporation Information
    Table 137. Johnson & Johnson Description and Major Businesses
    Table 138. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 139. Johnson & Johnson Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Johnson & Johnson Recent Developments
    Table 141. Sino Biopharmaceutical Corporation Information
    Table 142. Sino Biopharmaceutical Description and Major Businesses
    Table 143. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 144. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Sino Biopharmaceutical Recent Developments
    Table 146. Haohai Biological Corporation Information
    Table 147. Haohai Biological Description and Major Businesses
    Table 148. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 149. Haohai Biological Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Haohai Biological Recent Developments
    Table 151. Zhejiang Chengyi Pharmaceutical Corporation Information
    Table 152. Zhejiang Chengyi Pharmaceutical Description and Major Businesses
    Table 153. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 154. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Zhejiang Chengyi Pharmaceutical Recent Developments
    Table 156. Freda Corporation Information
    Table 157. Freda Description and Major Businesses
    Table 158. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 159. Freda Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Freda Recent Developments
    Table 161. Bright Future Corporation Information
    Table 162. Bright Future Description and Major Businesses
    Table 163. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 164. Bright Future Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Bright Future Recent Developments
    Table 166. Jingfeng Pharmaceutical Corporation Information
    Table 167. Jingfeng Pharmaceutical Description and Major Businesses
    Table 168. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 169. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Jingfeng Pharmaceutical Recent Developments
    Table 171. Chugai Pharmaceutical Corporation Information
    Table 172. Chugai Pharmaceutical Description and Major Businesses
    Table 173. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 174. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 175. Chugai Pharmaceutical Recent Developments
    Table 176. Mikasa Seiyaku Corporation Information
    Table 177. Mikasa Seiyaku Description and Major Businesses
    Table 178. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 179. Mikasa Seiyaku Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 180. Mikasa Seiyaku Recent Developments
    Table 181. Taisho Pharmaceutical Corporation Information
    Table 182. Taisho Pharmaceutical Description and Major Businesses
    Table 183. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 184. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 185. Taisho Pharmaceutical Recent Developments
    Table 186. Seikagaku Corporation Corporation Information
    Table 187. Seikagaku Corporation Description and Major Businesses
    Table 188. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 189. Seikagaku Corporation Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 190. Seikagaku Corporation Recent Developments
    Table 191. GlaxoSmithKline Corporation Information
    Table 192. GlaxoSmithKline Description and Major Businesses
    Table 193. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 194. GlaxoSmithKline Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 195. GlaxoSmithKline Recent Developments
    Table 196. Eli Lilly Corporation Information
    Table 197. Eli Lilly Description and Major Businesses
    Table 198. Eli Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 199. Eli Lilly Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 200. Eli Lilly Recent Developments
    Table 201. Novartis Corporation Information
    Table 202. Novartis Description and Major Businesses
    Table 203. Novartis Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 204. Novartis Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 205. Novartis Recent Developments
    Table 206. Horizon Pharma Corporation Information
    Table 207. Horizon Pharma Description and Major Businesses
    Table 208. Horizon Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 209. Horizon Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 210. Horizon Pharma Recent Developments
    Table 211. Abbott Corporation Information
    Table 212. Abbott Description and Major Businesses
    Table 213. Abbott Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 214. Abbott Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 215. Abbott Recent Developments
    Table 216. Mylan Corporation Information
    Table 217. Mylan Description and Major Businesses
    Table 218. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 219. Mylan Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 220. Mylan Recent Developments
    Table 221. Daiichi Sankyo Corporation Information
    Table 222. Daiichi Sankyo Description and Major Businesses
    Table 223. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 224. Daiichi Sankyo Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 225. Daiichi Sankyo Recent Developments
    Table 226. TEVA Corporation Information
    Table 227. TEVA Description and Major Businesses
    Table 228. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 229. TEVA Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 230. TEVA Recent Developments
    Table 231. Almatica Pharma Corporation Information
    Table 232. Almatica Pharma Description and Major Businesses
    Table 233. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 234. Almatica Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 235. Almatica Pharma Recent Developments
    Table 236. Astellas Pharma Corporation Information
    Table 237. Astellas Pharma Description and Major Businesses
    Table 238. Astellas Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 239. Astellas Pharma Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 240. Astellas Pharma Recent Developments
    Table 241. Tide Pharmaceutical Corporation Information
    Table 242. Tide Pharmaceutical Description and Major Businesses
    Table 243. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 244. Tide Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 245. Tide Pharmaceutical Recent Developments
    Table 246. Iroko Pharmaceuticals Corporation Information
    Table 247. Iroko Pharmaceuticals Description and Major Businesses
    Table 248. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 249. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 250. Iroko Pharmaceuticals Recent Developments
    Table 251. Hengrui Pharmaceutical Corporation Information
    Table 252. Hengrui Pharmaceutical Description and Major Businesses
    Table 253. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 254. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 255. Hengrui Pharmaceutical Recent Developments
    Table 256. Key Raw Materials Lists
    Table 257. Raw Materials Key Suppliers Lists
    Table 258. Osteoarthritis Pain Drugs Distributors List
    Table 259. Osteoarthritis Pain Drugs Customers List
    Table 260. Osteoarthritis Pain Drugs Market Trends
    Table 261. Osteoarthritis Pain Drugs Market Drivers
    Table 262. Osteoarthritis Pain Drugs Market Challenges
    Table 263. Osteoarthritis Pain Drugs Market Restraints
    Table 264. Research Programs/Design for This Report
    Table 265. Key Data Information from Secondary Sources
    Table 266. Key Data Information from Primary Sources
List of Figures
    Figure 1. Osteoarthritis Pain Drugs Product Picture
    Figure 3. Global Osteoarthritis Pain Drugs Market Share by Type in 2021 & 2028
    Figure 3. Oral Product Picture
    Figure 4. Injection Product Picture
    Figure 5. External Product Picture
    Figure 6. Global Osteoarthritis Pain Drugs Market Share by Application in 2021 & 2028
    Figure 7. Medical Care
    Figure 8. Personal Care
    Figure 9. Osteoarthritis Pain Drugs Report Years Considered
    Figure 10. Global Osteoarthritis Pain Drugs Sales 2017-2028 (M Dose)
    Figure 11. Global Osteoarthritis Pain Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Osteoarthritis Pain Drugs Revenue 2017-2028 (US$ Million)
    Figure 13. Global Osteoarthritis Pain Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2017-2022)
    Figure 15. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2023-2028)
    Figure 16. North America Osteoarthritis Pain Drugs Sales YoY (2017-2028) & (M Dose)
    Figure 17. North America Osteoarthritis Pain Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Osteoarthritis Pain Drugs Sales YoY (2017-2028) & (M Dose)
    Figure 19. Europe Osteoarthritis Pain Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Osteoarthritis Pain Drugs Sales YoY (2017-2028) & (M Dose)
    Figure 21. Asia-Pacific Osteoarthritis Pain Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Osteoarthritis Pain Drugs Sales YoY (2017-2028) & (M Dose)
    Figure 23. Latin America Osteoarthritis Pain Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Osteoarthritis Pain Drugs Sales YoY (2017-2028) & (M Dose)
    Figure 25. Middle East & Africa Osteoarthritis Pain Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Osteoarthritis Pain Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Osteoarthritis Pain Drugs in the World: Market Share by Osteoarthritis Pain Drugs Revenue in 2021
    Figure 28. Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2028)
    Figure 30. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2028)
    Figure 31. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2028)
    Figure 32. Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2017-2028)
    Figure 33. North America Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2028)
    Figure 34. North America Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. North America Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2028)
    Figure 36. North America Osteoarthritis Pain Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Osteoarthritis Pain Drugs Sales Share by Country (2017-2028)
    Figure 38. North America Osteoarthritis Pain Drugs Revenue Share by Country (2017-2028)
    Figure 39. U.S. Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2028)
    Figure 42. Europe Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2028)
    Figure 44. Europe Osteoarthritis Pain Drugs Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Osteoarthritis Pain Drugs Sales Share by Country (2017-2028)
    Figure 46. Europe Osteoarthritis Pain Drugs Revenue Share by Country (2017-2028)
    Figure 47. Germany Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. France Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Osteoarthritis Pain Drugs Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Osteoarthritis Pain Drugs Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Osteoarthritis Pain Drugs Revenue Share by Region (2017-2028)
    Figure 58. China Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. India Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Osteoarthritis Pain Drugs Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Osteoarthritis Pain Drugs Sales Share by Country (2017-2028)
    Figure 72. Latin America Osteoarthritis Pain Drugs Revenue Share by Country (2017-2028)
    Figure 73. Mexico Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Osteoarthritis Pain Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Middle East an
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
INQUIRE FOR DISCOUNT
HAVE A QUERY?
INQUIRE ABOUT REPORT EMAIL US
OUR CUSTOMER
Leap India
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Internal Neuromodulation Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-24F2529
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Pain Relief Patches - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14K2655
Wed Mar 27 00:00:00 UTC 2024

Add to Cart

Acetaminophen - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26Z11859
Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Global Muscle Pain Relief Patches Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6F17019
Thu Mar 21 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICIES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions